parathyroid hormone
NATPARA (parathyroid hormone) is hormone. Approved for hypoparathyroidism. First approved in 2015.
Drug data last refreshed 22h ago
hormone. Parathyroid hormone raises serum calcium by increasing renal tubular calcium reabsorption, increasing intestinal calcium absorption (i.e., by converting 25-OH vitamin D to 1,25-OH 2 vitamin D) and by increasing bone turnover which releases calcium into the circulation.
Parathyroid Hormone
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.